Francesco Salvo

Bordeaux, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 152 publications

Reply to "A Comment about AI Methods that May Help Advance Pharmacovigilance".

Reply to "A Comment about AI Methods that May Help Advance Pharmacovigilance".

Journal: Clinical pharmacology and therapeutics

Published: April 17, 2026

Redundant pharmacovigilance disproportionality analyses: Navigating between Scylla and Charybdis.

Redundant pharmacovigilance disproportionality analyses: Navigating between Scylla and Charybdis.

Journal: Headache

Published: April 06, 2026

Language models in pharmacovigilance: Applications, promises and limits.

Language models in pharmacovigilance: Applications, promises and limits.

Journal: Therapie

Published: November 04, 2025

The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence-Based Medicine.

The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence-Based Medicine.

Journal: Clinical pharmacology and therapeutics

Published: November 04, 2025

Hepatobiliary adverse drug reactions during treatment with olaparib: an analysis of data from the EudraVigilance reporting system.

Hepatobiliary adverse drug reactions during treatment with olaparib: an analysis of data from the EudraVigilance reporting system.

Journal: Frontiers in drug safety and regulation

Published: October 31, 2025

Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database.

Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database.

Journal: Drug safety

Published: June 23, 2025

Standardizing and Comparing Management Recommendations for Potential Drug-Drug Interactions Across Different Interaction Checkers.

Standardizing and Comparing Management Recommendations for Potential Drug-Drug Interactions Across Different Interaction Checkers.

Journal: Drug safety

Published: June 20, 2025

FDA Adverse Event Reporting System Essentials: A Reflection on Study Conception.

FDA Adverse Event Reporting System Essentials: A Reflection on Study Conception.

Journal: Clinical pharmacology and therapeutics

Published: June 19, 2025

Letter to the Editor From Raschi et al: "Endocrine Adverse Reactions of Tyrosine Kinase Inhibitors in Combination With Immune Checkpoint Inhibitors".

Letter to the Editor From Raschi et al: "Endocrine Adverse Reactions of Tyrosine Kinase Inhibitors in Combination With Immune Checkpoint Inhibitors".

Journal: The Journal of clinical endocrinology and metabolism

Published: April 28, 2025

Drugs associated with generalized nonallergic pruritus: A World Health Organization pharmacovigilance database analysis.

Drugs associated with generalized nonallergic pruritus: A World Health Organization pharmacovigilance database analysis.

Journal: Journal of the American Academy of Dermatology

Published: April 24, 2025

Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database.

Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database.

Journal: Drug safety

Published: April 22, 2025

Coprescription of antipsychotics and benzodiazepines at hospital discharge.

Coprescription of antipsychotics and benzodiazepines at hospital discharge.

Journal: L'Encephale

Published: February 21, 2025

Showing 1-12 of 152

Last Updated: 09/26/2026